David Francis Carroll, SVP, Chief Financial Officer at IVERIC bio, Inc. (ISEE), sold 98,171 shares at $30.00 ($3.0M) on 2023-04-21, disclosed to the SEC on 2023-04-25.
Scheduled sale ($3.0M) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 1,829 | $55K | 1.9% |
| 2 | $30.21 | 48,171 | $1.5M | 49.1% |
| 3 | $30.21 | 48,171 | $1.5M | 49.1% |
| Total | $30.21 avg | 98,171 | $3.0M | 100% |
| Filing → |
| ISEE | SELL | 2022-12-20 | $244K | — | Filing → |
| ISEE | SELL | 2022-12-13 | $297K | — | Filing → |
| ISEE | SELL | 2022-04-05 | $1.7M | — | Filing → |